Question
Slow virus diseases
Answer
Slow virus diseases are a group of chronic, progressive CNS infections characterized by an unusually long incubation period (months to years) between initial infection and onset of clinical disease, followed by a slowly progressive, generally fatal course — a pattern distinct from the typical acute infection-and-resolution course of most viral illnesses.
Classical examples:
- Subacute Sclerosing Panencephalitis (SSPE) — a rare, late (years after primary infection, typically in childhood/adolescence), progressive, fatal complication of measles virus infection, caused by a persistent, defective form of the virus within CNS neurons; presents with progressive cognitive decline, myoclonic jerks, and eventual death.
- Progressive Multifocal Leukoencephalopathy (PML) — caused by reactivation of latent JC virus (a polyomavirus) in severely immunocompromised patients (advanced HIV/AIDS, or those on certain immunosuppressive/immunomodulatory therapies, e.g., natalizumab); causes progressive demyelination and rapidly progressive neurological decline.
- Prion diseases (Creutzfeldt-Jakob disease, kuru, and other transmissible spongiform encephalopathies) — though caused by an entirely different class of agent (infectious protein, prion, with no nucleic acid at all) rather than a conventional virus, these were historically grouped under the “slow virus disease” concept given the shared clinical pattern of prolonged incubation and progressive fatal neurodegeneration; this term is now recognized as a misnomer for prion disease specifically, given their non-viral nature, but the historical classification is still sometimes referenced.
Common pathogenic principle: these conditions typically involve either a persistent, low-level, defective viral infection evading normal immune clearance (SSPE, PML), or an entirely novel disease mechanism (prion self-templating protein misfolding) — in both cases producing a prolonged latent/subclinical period before eventual progressive, irreversible neurological damage becomes clinically apparent.